The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...
The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...
Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.
Europe's medicines regulator on Friday recommended granting marketing authorisation to mCombriax, making Moderna's messenger RNA vaccine the world's first combined shot for ...
Initial tender contract of EUR 13 million supports gated advancement into two subsequent competitive phasesMUNICH, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ethris GmbH, a clinical-stage biotechnology company ...
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
Reversing its initial decision, the FDA has agreed to review Moderna’s messenger RNA-based influenza vaccine for approval, the company announced Wednesday. The reversal about weeks after the FDA sent ...
The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.
Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results